J Metab Bariatr Surg 2022
For that, see Provns article on how GLP-1 medications work for weight loss
The subcutaneous route ensures gradual, sustained absorption into the bloodstream, which is essential for maintaining therapeutic drug levels and minimising side effects
However, clinical trials investigating GLP-1RAs in diseases such as AD, PD, mild cognitive impairment, psychiatric disorders, and diabetes have yielded mixed results for cognitive and motor function
The minimum BMI for semaglutide (Wegovy) under FDA labeling is 30 without any additional conditions, or 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
These cases had a subtle onset and were accompanied by non-specific symptoms such as malaise, myalgias, abdominal pain, respiratory distress, or increased somnolence